Similar articles

• Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.

  Joanis CL, Hart CW. Joanis CL, et al. AIDS Behav. 2010 Jun;14(3):600-6. doi: 10.1007/s10461-009-9655-6. AIDS Behav. 2010. PMID: 20049522 Clinical Trial.
• Specific microbicides in the prevention of HIV infection.

  Kelly CG, Shattock RJ. Kelly CG, et al. J Intern Med. 2011 Dec;270(6):509-19. doi: 10.1111/j.1365-2796.2011.02454.x. Epub 2011 Oct 27. J Intern Med. 2011. PMID: 21917029 Review.
• [The acceptability on vaginal microbicides to prevent human immunodeficiency virus/sexually transmitted diseases].

  Han L, Wu ZL. Han L, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Feb;30(2):196-8. Zhonghua Liu Xing Bing Xue Za Zhi. 2009. PMID: 19565887 Review. Chinese. No abstract available.
• The slow evolution of microbicides for STD/HIV prevention.

  Howes J, Bass M. Howes J, et al. J Gend Specif Med. 1999 May-Jun;2(3):22-3. J Gend Specif Med. 1999. PMID: 11252848 No abstract available.
• Female controlled methods of contraception and sexually transmitted infections including HIV in Malawi: examining the role of the female condom and microbicides.

  Bisika T. Bisika T. East Afr J Public Health. 2009 Aug;6(2):223-5. doi: 10.4314/eajph.v6i2.51791. East Afr J Public Health. 2009. PMID: 20000034 No abstract available.